SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001566044-21-000032
Filing Date
2021-08-12
Accepted
2021-08-12 08:36:34
Documents
23
Period of Report
2021-08-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mnlo-20210812.htm   iXBRL 8-K 45429
2 EX-99.1 vyne-2021812q2x2021exx991.htm EX-99.1 291356
3 EX-99.2 ex992vyne-xlicensingofbeti.htm EX-99.2 25841
4 EX-99.3 ex993betiintroduction_fi.htm EX-99.3 10310
8 ex993betiintroduction_fi001.jpg GRAPHIC 103826
9 ex993betiintroduction_fi002.jpg GRAPHIC 157937
10 ex993betiintroduction_fi003.jpg GRAPHIC 56313
11 ex993betiintroduction_fi004.jpg GRAPHIC 131549
12 ex993betiintroduction_fi005.jpg GRAPHIC 105560
13 ex993betiintroduction_fi006.jpg GRAPHIC 122285
14 image.jpg GRAPHIC 33776
15 picture1.jpg GRAPHIC 10578
  Complete submission text file 0001566044-21-000032.txt   1555303

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mnlo-20210812.xsd EX-101.SCH 2026
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mnlo-20210812_lab.xml EX-101.LAB 25136
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mnlo-20210812_pre.xml EX-101.PRE 13154
16 EXTRACTED XBRL INSTANCE DOCUMENT mnlo-20210812_htm.xml XML 11681
Mailing Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807
Business Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38356 | Film No.: 211165606
SIC: 2834 Pharmaceutical Preparations